BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24460352)

  • 1. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
    Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
    Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
    Thongbai C; Sa-nguanmoo P; Kranokpiruk P; Poovorawan K; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.
    Villar S; Le Roux-Goglin E; Gouas DA; Plymoth A; Ferro G; Boniol M; Lereau M; Bah E; Hall AJ; Wild CP; Mendy M; Norder H; van der Sande M; Whittle H; Friesen MD; Groopman JD; Hainaut P
    Environ Health Perspect; 2011 Nov; 119(11):1635-40. PubMed ID: 21768053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
    Ortiz-Cuaran S; Villar S; Gouas D; Ferro G; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    Cancer Lett; 2013 Apr; 331(1):46-51. PubMed ID: 23200676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
    Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
    Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
    Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
    Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
    Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
    Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.
    Shiota G; Oyama K; Udagawa A; Tanaka K; Nomi T; Kitamura A; Tsutsumi A; Noguchi N; Takano Y; Yashima K; Kishimoto Y; Suou T; Kawasaki H
    J Med Virol; 2000 Oct; 62(2):151-8. PubMed ID: 11002243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.